Xtnac-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100 mg), Paracetamol (325 mg), and Serratiopeptidase (15 mg). Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis. Paracetamol provides analgesic and antipyretic effects by acting centrally to inhibit pain pathways and reduce fever. Serratiopeptidase is a proteolytic enzyme that facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and swelling. This synergistic combination is indicated for the management of acute and chronic musculoskeletal pain, including osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue injuries. Xtnac-SP Tablet offers rapid and sustained relief from pain and inflammation while aiding in the reduction of tissue swelling. It is generally well tolerated; however, caution is advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to any component. The medication should be taken as prescribed by a healthcare professional, with consideration of contraindications and potential drug interactions. Regular monitoring may be necessary during prolonged therapy to ensure safety and efficacy.